Resveratrol attenuates inflammation environment-induced nucleus pulposus cell senescence in vitro

Biosci Rep. 2019 May 10;39(5):BSR20190126. doi: 10.1042/BSR20190126. Print 2019 May 31.

Abstract

Intervertebral disc degeneration is a disease identified as an inflammation response-participated pathological process. As a classical cellular feature, disc cell senescence is reported to be closely related with disc cell senescence. Resveratrol has a protective role against inflammation in some cells. However, its biological effects on disc cells remain largely unclear. The present study was aimed to study the effects of resveratrol on disc nucleus pulposus (NP) cell senescence in an inflammation environment. Isolated NP cells were cultured in cultured medium with (control group) or without (inflammation group) inflammatory cytokine TNF-α and IL-1β for 14 days. Resveratrol was added along with the NP cells treated with inflammatory cytokines to investigate its effects. NP cell senescence was analyzed by senescence-associated β-Galactosidase (SA-β-Gal) staining, cell proliferation, G0/1 cell cycle arrest, telomerase activity, gene/protein expression of senescence markers (p16 and p53) and NP matrix biosynthesis. In addition, the intracellular reactive oxygen species (ROS) was also analyzed. Compared with the control group, inflammation group significantly increased SA-β-Gal activity and ROS content, decreased cell proliferation and telomerase activity, promoted G0/1 cell cycle arrest, up-regulated gene/protein expression of senescence markers (p16 and p53) and matrix catabolism enzymes (MMP-3, MMP-13 and ADAMTS-4), and down-regulated gene/protein expression of NP matrix macromolecules (aggrecan and collagen II). However, resveratrol partly reversed the effects of inflammatory cytokine on these cell senescence-associated parameters. Together, resveratrol was effective to suppress cell senescence in an inflammatory environment. The present study shows new knowledge on how to retard inflammation response-initiated disc degeneration.

Keywords: cell senescence; intervertebral disc degeneration; nucleus pulposus; resveratrol.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADAMTS4 Protein / genetics
  • ADAMTS4 Protein / metabolism
  • Aggrecans / genetics
  • Aggrecans / metabolism
  • Animals
  • Antioxidants / pharmacology*
  • Cellular Senescence / drug effects
  • Chondrocytes / cytology
  • Chondrocytes / drug effects*
  • Chondrocytes / metabolism
  • Collagen Type II / genetics
  • Collagen Type II / metabolism
  • Cyclin-Dependent Kinase Inhibitor p16 / genetics
  • Cyclin-Dependent Kinase Inhibitor p16 / metabolism
  • G1 Phase Cell Cycle Checkpoints / drug effects
  • G1 Phase Cell Cycle Checkpoints / genetics
  • Gene Expression Regulation / drug effects*
  • Inflammation
  • Interleukin-1beta / antagonists & inhibitors
  • Interleukin-1beta / pharmacology
  • Matrix Metalloproteinases / genetics
  • Matrix Metalloproteinases / metabolism
  • Nucleus Pulposus / cytology
  • Nucleus Pulposus / metabolism
  • Oxidative Stress
  • Primary Cell Culture
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species / antagonists & inhibitors*
  • Reactive Oxygen Species / metabolism
  • Resveratrol / pharmacology*
  • Signal Transduction
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / pharmacology
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism
  • beta-Galactosidase / genetics
  • beta-Galactosidase / metabolism

Substances

  • Aggrecans
  • Antioxidants
  • Collagen Type II
  • Cyclin-Dependent Kinase Inhibitor p16
  • IL1B protein, rat
  • Interleukin-1beta
  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha
  • Tumor Suppressor Protein p53
  • beta-Galactosidase
  • ADAMTS4 protein, rat
  • Matrix Metalloproteinases
  • ADAMTS4 Protein
  • Resveratrol